The average length of the human gut is 25 feet long. That’s equivalent to four really tall people or five really short people lined up head to toe. Intestinal stem cells have the fun job of regenerating and replacing ALL the cells that line the gut. Therefore, it’s important for these stem cells to be … Continue reading Keeping intestinal stem cells in their prime
News
jCyte gets FDA go-ahead for Fast Track review process of Retinitis Pigmentosa stem cell therapy
When the US Congress approved, and President Obama signed into law, the 21st Century Cures Act last year there was guarded optimism that this would help create a more efficient and streamlined, but no less safe, approval process for the most promising stem cell therapies. Even so many people took a wait and see approach, … Continue reading jCyte gets FDA go-ahead for Fast Track review process of Retinitis Pigmentosa stem cell therapy
CIRM’s Randy Mills leaving stem cell agency to take on new challenge
Some news releases are fun to write. Some less so. The one that CIRM posted today definitely falls into that latter group. It announced that CIRM’s President and CEO, Randy Mills, is leaving us to take up the role of President and CEO at the National Marrow Donor Program – NMPD/Be The Match. It’s a … Continue reading CIRM’s Randy Mills leaving stem cell agency to take on new challenge
Stem cell-derived, 3D brain tissue reveals autism insights
Studying human brain disorders is one of the most challenging fields in biomedical research. Besides the fact that the brain is incredibly complex, it’s just plain difficult to peer into it. For one thing, it’s not practical, let alone ethical, to drill into an affected person’s skull and collect brain cells to learn about their … Continue reading Stem cell-derived, 3D brain tissue reveals autism insights
Stem cell stories that caught our eye: spinal cord injury trial keeps pace; SMART cells make cartilage and drugs
CIRM-funded spinal cord injury trial keeping a steady pace Taking an idea for a stem cell treatment and developing it into a Food and Drug Administration-approved cell therapy is like running the Boston Marathon because it requires incremental progress rather than a quick sprint. Asterias Biotherapeutics continues to keep a steady pace and to hit … Continue reading Stem cell stories that caught our eye: spinal cord injury trial keeps pace; SMART cells make cartilage and drugs
Capricor reports positive results on CIRM-funded stem cell trial for Duchenne Muscular Dystrophy
Capricor Therapeutics, a Los Angeles-based company, published an update about its CIRM-funded clinical trial for patients with Duchenne muscular dystrophy (DMD), a devastating degenerative muscle disease that significantly reduces life expectancy. The company reported positive results from their Phase I/II HOPE trial that’s testing the safety of their cardiosphere stem cell-based therapy called CAP-1002. The trial had … Continue reading Capricor reports positive results on CIRM-funded stem cell trial for Duchenne Muscular Dystrophy
Scientists make stem cell-derived nerve cells damaged in spinal cord injury
The human spinal cord is an information highway that relays movement-related instructions from the brain to the rest of the body and sensory information from the body back to the brain. What keeps this highway flowing is a long tube of nerve cells and support cells bundled together within the spine. When the spinal cord … Continue reading Scientists make stem cell-derived nerve cells damaged in spinal cord injury
Stem Cell Patient Advocates, Scientists and Doctors Unite Around a Common Cause
Some phrases just bring a smile to your face: “It’s a girl/boy”, “Congratulations, you got the job”, and “Another beer sir?” (or maybe that last one is just me). One other phrase that makes me smile is “packed house”. That’s why I was smiling so much at our Patient Advocate Event at UC San Diego … Continue reading Stem Cell Patient Advocates, Scientists and Doctors Unite Around a Common Cause
Stem cell stories that caught our eye: developing the nervous system, aging stem cells and identical twins not so identical
Here are the stem cell stories that caught our eye this week. Enjoy! New theory for how the nervous system develops. There’s a new theory on the block for how the nervous system is formed thanks to a study published yesterday by UCLA stem cell scientists in the journal Neuron. The theory centers around axons, thin … Continue reading Stem cell stories that caught our eye: developing the nervous system, aging stem cells and identical twins not so identical
jCyte starts second phase of stem cell clinical trial targeting vision loss
Studies show that Americans fear losing their vision more than any other sense, such as hearing or speech, and almost as much as they fear cancer, Alzheimer’s and HIV/AIDS. That’s not too surprising. Our eyes are our connection to the world around us. Sever that connection, and the world is a very different place. For … Continue reading jCyte starts second phase of stem cell clinical trial targeting vision loss
The Stem Cellar 